Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Peripheral biomarkers are crucial for disease diagnosis and monitoring.
• MicroRNA (miRNA) expression in circulation correlates with neurological changes in psychiatric disorders.
• miRNAs epigenetically regulate brain function and are linked to behavioral changes.

Purpose of the Study:

• To critically evaluate microRNAs as diagnostic and prognostic biomarkers for psychiatric disorders.
• To assess the potential of miRNAs in predicting treatment response.
• To review the advantages and disadvantages of using miRNAs in clinical practice.

Main Methods:

• Literature review of studies investigating miRNA expression in psychiatric disorders.
• Analysis of empirical evidence linking miRNA changes to brain function and behavior.
• Evaluation of clinical data on miRNA utility in major depressive disorder, bipolar disorder, and schizophrenia.

Main Results:

• miRNA expression changes in peripheral tissues are associated with neuropsychiatric conditions.
• miRNAs influence brain functioning and are implicated in major psychiatric disorders.
• Evidence suggests miRNAs can serve as biomarkers for diagnosis, prognosis, and treatment response.

Conclusions:

• miRNAs hold significant potential as non-invasive biomarkers for psychiatric disorders.
• Further research is needed to fully establish their clinical utility and overcome limitations.
• miRNAs may offer novel avenues for managing major depressive disorder, bipolar disorder, and schizophrenia.